Canadian pharmaceutical industry alarmed after Trump floats 200 per cent tariff

WASHINGTON — Canada likely isn’t the main target of U.S. WASHINGTON — Canada likely isn’t the main target of U.S. President Donald Trump’s threat to impose a 200 per cent tariff on pharmaceutical imports, an industry representative said Wednesday — but his plan could still put parts of the Canadian sector in peril. “Canada is not the target but we could get caught in the crossfire if there are broad-based tariffs on pharmaceuticals,” said Canadian Generic Pharmaceutical Association president Jim Keon. On Tuesday, Trump floated the idea of massive pharmaceutical tariffs but said he would give drug makers up to…